# FDA recall D-518-2014

> **Aidapak Services, LLC** · Class II · drug recall initiated 2013-07-02.

## Product

FAMOTIDINE Tablet, 20 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 16714036104

## Reason for recall

Labeling: Label Mixup; FAMOTIDINE Tablet, 20 mg may be potentially mislabeled as    CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, NDC 00007337113, Pedigree: W003225, EXP: 6/17/2014;  DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003506, EXP: 6/21/2014;  FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003507, EXP: 6/21/2014;  MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 0037822500

## Distribution

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

## Key facts

- **Recall number:** D-518-2014
- **Recalling firm:** Aidapak Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-07-02
- **Report date:** 2014-01-22
- **Termination date:** 2014-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vancouver, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-518-2014

## Citation

> AI Analytics. FDA recall D-518-2014. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-518-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*